Lumito and Offspring Biosciences initiate pilot study to combine automated, standardised workflows with high‑sensitivity tissue analysis
Lumito AB (publ) (“Lumito” or the “Company”) and Offspring Biosciences Sweden AB (“Offspring Biosciences”) today announce the initiation of a pilot study. The purpose is to evaluate the integration of Lumito’s proprietary tissue labelling and high-sensitivity imaging platform within Offspring Biosciences’ automated analytical workflows based on Roche Ventana Discovery Ultra. The pilot study will commence […]
Lumito AB publishes year-end report 2025
Financial overviewFourth quarter 2025, 1 October – 31 DecemberNet sales amounted to 0 (79) KSEK.Result after taxes amounted to -11,244 (-15,476) KSEK.Earnings per share before and after dilution amounted to -0.01 (-0.06) SEK.Cash flow from operating activities amounted to -8,616 (-8,713) KSEK. Full year 2025, 1 January – 31 DecemberNet sales amounted to 0 (97) KSEK.Result […]
Invitation to webinar in connection with Lumito AB’s year-end report for 2025
Lumito AB (publ) (“Lumito” or the “Company”) will publish its year-end report for 2025 on 20 February 2026. In connection with the publication, shareholders, investors, and other stakeholders are invited to a webinar on the same day at 14:30 CET. During the session, the Company’s CEO, Sanna Wallenborg, will provide a brief introduction to Lumito and […]
Lumito AB publishes year-end report 2024
Financial Overview Fourth quarter 2024, October 1 to December 31• Net sales amounted to TSEK 79 (0).• Result after taxes amounted to TSEK-15,476 (-5,777).• Earnings per share before and after dilution amounted to SEK -0.06 (-0.03).• Cash flow from operating activities after changes in working capital amounted to TSEK -6,213 (-5,480). Full Year 2024, 1 […]
Lumito AB publishes Quarterly Report 4, 2023
Financial overviewFourth quarterOctober 1 – December 31, 2023 Net sales amounted to TSEK 0 (0). Result after taxes amounted to TSEK -5 777 (-6 612). Earnings per share before and after dilution amounted to SEK -0,03 (-0,03). Cash flow from operating activities after changes in working capital amounted to TSEK -5 480 (-5 153). Full […]